| Source: |
| Type: |
| Overall survival |
| 2326- | 2DG, | Caloric Restriction Mimetic 2-Deoxyglucose Alleviated Inflammatory Lung Injury via Suppressing Nuclear Pyruvate Kinase M2–Signal Transducer and Activator of Transcription 3 Pathway |
| - | in-vivo, | Nor, | NA |
| 5281- | 3BP, | A translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside |
| - | Case Report, | Var, | NA |
| 5278- | 3BP, | The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | Caco-2 | - | in-vitro, | CRC, | SW48 |
| 5264- | 3BP, | Candidate cancer drug suspected after death of three patients at an alternative medicine clinic |
| - | Review, | Var, | NA |
| - | in-vitro, | Lung, | NA |
| 5440- | AG, | Astragalus Injection Enhances the Sensitivity of Clinical Cancer Patients to Chemotherapy: A Systematic meta-Analysis |
| - | Review, | Var, | NA |
| 4402- | AgNPs, | Enhancement of Triple-Negative Breast Cancer-Specific Induction of Cell Death by Silver Nanoparticles by Combined Treatment with Proteotoxic Stress Response Inhibitors |
| - | in-vitro, | BC, | BT549 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 4394- | AgNPs, | Silver nanoparticles provoke apoptosis of Dalton's ascites lymphoma in vivo by mitochondria dependent and independent pathways |
| - | in-vivo, | lymphoma, | NA |
| 4362- | AgNPs, | Enhancing Colorectal Cancer Radiation Therapy Efficacy using Silver Nanoprisms Decorated with Graphene as Radiosensitizers |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT29 | - | in-vivo, | NA, | NA |
| 333- | AgNPs, | HPT, | Enhancement effect of cytotoxicity response of silver nanoparticles combined with thermotherapy on C6 rat glioma cells |
| - | in-vivo, | GBM, | NA |
| 332- | AgNPs, | Rad, | Enhancement of Radiosensitization by Silver Nanoparticles Functionalized with Polyethylene Glycol and Aptamer As1411 for Glioma Irradiation Therapy |
| - | in-vivo, | GBM, | NA |
| 331- | AgNPs, | Rad, | Silver nanoparticles: a novel radiation sensitizer for glioma? |
| - | vitro+vivo, | GBM, | NA |
| 305- | AgNPs, | Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer |
| - | Case Report, | HNSCC, | NA |
| 345- | AgNPs, | Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model |
| - | vitro+vivo, | lymphoma, | NA |
| - | Case Report, | Melanoma, | NA |
| 287- | ALA, | HCA, | Lyco, | Metabolic treatment of cancer: intermediate results of a prospective case series |
| 290- | ALA, | HCA, | A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results |
| - | vitro+vivo, | Melanoma, | B16-F10 |
| 274- | ALA, | LDN, | Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases |
| - | Human, | PC, | NA |
| 5325- | ALC, | L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial |
| - | Trial, | PC, | NA |
| - | Trial, | NSCLC, | NA |
| 5360- | almon, | BEV, | Case report: Almonertinib in combination with bevacizumab for leptomeningeal metastases from epidermal growth factor receptor-mutation non-small cell lung cancer: Case series |
| - | Case Report, | NSCLC, | NA |
| - | Trial, | NSCLC, | NA |
| 4759- | antiOx, | Chemo, | Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization |
| - | Review, | Var, | NA |
| 4760- | antiOx, | Chemo, | Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials |
| - | Review, | Var, | NA |
| 4765- | antiOx, | Chemo, | Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity – Exploring the armoury of obscurity |
| - | Review, | Var, | NA |
| 2593- | Api, | Apigenin promotes apoptosis of 4T1 cells through PI3K/AKT/Nrf2 pathway and improves tumor immune microenvironment in vivo |
| - | in-vivo, | BC, | 4T1 |
| 1541- | Api, | EGCG, | Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence |
| - | Human, | NA, | NA |
| 2002- | Ash, | Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology |
| - | Review, | Var, | NA |
| 5372- | ATO, | Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia |
| - | Trial, | APL, | NA |
| - | Trial, | APL, | NA |
| 5374- | ATO, | A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemia |
| - | Trial, | APL, | NA |
| 5453- | ATV, | Epidemiologic Analysis Along the Mevalonate Pathway Reveals Improved Cancer Survival in Patients Who Receive Statins Alone and in Combination With Bisphosphonates |
| - | Trial, | Var, | NA |
| 5449- | ATV, | Pleiotropic effects of statins: A focus on cancer |
| - | NA, | Var, | NA |
| 4981- | ATV, | Crosstalk between Statins and Cancer Prevention and Therapy: An Update |
| 5581- | B-Gluc, | Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases |
| - | Human, | GC, | NA |
| 5568- | B-Gluc, | immuno, | Beta-glucans in oncology: revolutionizing treatment with immune power & tumor targeting |
| - | Review, | Var, | NA |
| 5567- | B-Gluc, | Trained immunity: A new player in cancer immunotherapy |
| - | Review, | Var, | NA |
| 5566- | B-Gluc, | The effects of beta-glucan on human immune and cancer cells |
| - | Review, | Var, | NA |
| 5576- | B-Gluc, | Chemo, | Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy |
| - | Trial, | GC, | NA |
| 5577- | B-Gluc, | Lentinan progress in inflammatory diseases and tumor diseases |
| - | Review, | Var, | NA | - | Review, | IBD, | NA |
| - | Trial, | GC, | NA |
| 5580- | B-Gluc, | Lentinan, a Shiitake Mushroom β-Glucan, Downregulates the Enhanced PD-L1 Expression Induced by Platinum Compounds in Gastric Cancer Cells |
| - | in-vitro, | GC, | MKN45 |
| 5499- | Ba, | Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo |
| - | vitro+vivo, | Lung, | H460 | - | vitro+vivo, | Lung, | A549 |
| 1376- | BBR, | immuno, | Berberine sensitizes immune checkpoint blockade therapy in melanoma by NQO1 inhibition and ROS activation |
| - | in-vivo, | Melanoma, | NA |
| 5516- | BEV, | immuno, | Chemo, | Targeting vascular normalization: a promising strategy to improve immune–vascular crosstalk in cancer immunotherapy |
| - | Review, | Var, | NA |
| 5595- | BEV, | Chemo, | Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer |
| - | Human, | CRC, | NA |
| 5623- | Bif, | Bifidobacterium breve predicts the efficacy of anti-PD-1 immunotherapy combined with chemotherapy in Chinese NSCLC patients |
| - | Study, | NSCLC, | NA |
| 5628- | Bif, | immuno, | Bifidobacterium modulation of tumor immunotherapy and its mechanism |
| - | Review, | Var, | NA |
| 5692- | BJ, | Seed oil of Brucea javanica induces apoptosis through the PI3K/Akt signaling pathway in acute lymphocytic leukemia Jurkat cells |
| - | vitro+vivo, | AML, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:229 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid